echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Evidence-Based Medicine is worth reading!

    Evidence-Based Medicine is worth reading!

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Guided reading

    Active surveillance (AS) is an alternative to curative treatment options (surgery, radiotherapy, etc.




    To resolve these controversies, a Dutch research team conducted this evidence-based study




    We included all prospective and retrospective studies related to AS based on the Priority Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement




    The researchers screened 333 studies from 17,011 literatures and extracted 375 AS protocols




    Based on this SR, for AS protocols without MRI, the investigators recommend: (1) Low-risk patients with International Society of Urology Pathology Classification (ISUP) 2, or a single intermediate-risk factor (excluding ISUP 3) (2) Patients with low-risk but more extensive involvement (number of positive needles ≥ 3 or CI > 50%) PCa patients in ISUP grade 1 should be closely monitored, while similar patients in ISUP grade 2 should be closely monitored.



    references:

    Willemse PM, Davis NF, Grivas N, et al.


    END

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.